ºÚÁϳԹÏÍø

Skip to main content

Case Comprehensive Cancer Center

cancer-cells-feat
Hero Type
Image
Faculty members discuss nature of treating cancer in teenagers and young adults
Young adults often "forgotten individuals" in cancer research ideastream: Stanton L. Gerson, director of the Case Comprehensive Cancer Center and the Asa and Patricia Shiverick–Jane Shiverick (Tripp) Professor of Hematological Oncology, and John Letterio, professor of pediatrics, discussed the natu...
immunotherapy
Hero Type
Image
Using artificial intelligence to determine whether immunotherapy is working
ºÚÁϳԹÏÍø researchers use AI with routine CT scans to predict how well lung cancer patients will respond to expensive treatment based off changes in texture patterns inside and outside the tumor Scientists from the ºÚÁϳԹÏÍø digital imaging lab, already pioneering t...
Stark Honored with 2019 Steven C. Beering Award
The Case Comprehensive Cancer Center extends congratulations to George Stark, PhD as he was honored with the prestigious Steven C. Beering Award earlier this month. From the Cleveland Clinic Lerner Research Institute: The prestigious award recognizes internationally regarded scientists for their co...
dna-feat
Hero Type
Image
Non-coding DNA located outside chromosomes may help drive glioblastoma
Extra DNA scooped up and copied alongside cancer-causing genes helps keep tumors going—elements that could represent new drug targets for brain tumors and other cancers notoriously difficult to treat One of the ways a cancer-causing gene works up enough power to turn a normal cell into a cancer cel...
Moore Named Director of Breast Medical Oncology at Cleveland Clinic
The Case Comprehensive Cancer Center extends congratulations to Halle Moore, MD, as earlier this week she was named director of breast medical oncology and co-director for the Comprehensive Breast Cancer Program at Cleveland Clinic. Dr. Moore joined Cleveland Clinic in 1999 and will assume her new r...
Director's Message: Administration Leadership Update
Dear members of the Case Comprehensive Cancer Center community: I am happy to announce that John Pounardjian, MBA has been appointed Associate Director of Administration at our exceptional center. This appointment comes after an extensive national search following the departure of former Associate...
Alumni of YES Program at Case CCC Earns Medal for Gene Mutation Research
For the past three years, the National Cancer Institute has funded the Youth Engaged in Science (YES) program at ºÚÁϳԹÏÍø (ºÚÁϳԹÏÍø), introducing and training underrepresented minorities to cancer care and research professions. The program is led by Nathan Berger, MD. Program alu...
cancer-feat
Hero Type
Image
Student’s curiosity about his family’s cancer history fuels award-winning research project
Participant in Youth Engaged in Science, a National Cancer Institute-funded program at ºÚÁϳԹÏÍø Connor Harris, a science-minded teenager from Hudson, Ohio, wants to know why African-Americans die from colorectal cancer at a higher rate than other racial groups. His curiosity, fueled by...
Special Message: William Kaelin Receives Nobel Prize in Physiology or Medicine for Research on Oxygen Sensing
William Kaelin, Jr., MD William Kaelin, Jr. from Dana Farber Cancer Institute and Harvard University was jointly awarded the 2019 Nobel Prize in Physiology or Medicine, along with Sir Peter J. Ratcliffe from Oxford University and Francis Crick Institute and Gregg L. Semenza from Johns Hop...
Hoimes Presented Promising Initial Results of Enfortumab Vedotin plus Pembrolizumab in Urothelial Cancer at ESMO 2019
“Enfortumab vedotin plus pembrolizumab has the potential to become a platinum-free option for cisplatin-ineligible locally advanced and metastatic urothelial cancer patients in the first-line setting," said Christopher J. Hoimes, DO, hematologist/oncologist at University Hospitals, assistant profess...